TOTAL APLASIA OF THE RED BONE MARROW AS A RESULT OF TREATMENT WITH ERYTHROPOIETIN
https://doi.org/10.24884/1561-6274-2004-8-4-41-44
Abstract
Total aplasia of the red bone marrow as a result of treatment with erythropoietin.
About the Authors
E. A. Orlova
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
S. V. Lashutin
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
References
1. Eckardt KU, Casadevall N. Pure redcell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003 18: 865869
2. Casadevall N, Nataf J, Viron B et al. Pure redcell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469–475
3. Casadevall N, Dupuy E, MolhoSabatier P et al. Autoantibodies against erythropoietin in a patient with pure redcell aplasia. N Engl J Med 1996; 334: 630–633
4. Casadevall N. Antibodies against rHuEpo: native and recombinant. Nephrol Dial Transplant 2002; 17 [Suppl 5]: 42–47
5. Locatelli F, Del Vecchio L. Pure red cell aplasia secondary to treatment with erythropoietin. Artificial Organs 2003; 27(9):755–758
6. Locatelli F, Aljama P, Barany P et al. Erythropoiesis stimulating agents and antibodymediated pure redcell aplasia: where are we now and where do we go from here? Nephrol Dial Transplant 2004 19: 288293
Review
For citations:
Orlova E.A., Lashutin S.V. TOTAL APLASIA OF THE RED BONE MARROW AS A RESULT OF TREATMENT WITH ERYTHROPOIETIN. Nephrology (Saint-Petersburg). 2004;8(4):41-44. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-4-41-44
Views:
401
Email this article 